Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors

Abstract Background When sentinel node dissection reveals breast cancer metastasis, completion axillary lymph node dissection is ideally performed during the same operation. Intraoperative histologic techniques have low and variable sensitivity. A new intraoperative molecular assay (GeneSearch BLN A...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of surgery 2007-10, Vol.194 (4), p.426-432
Main Authors: Blumencranz, Peter, M.D, Whitworth, Pat W., M.D, Deck, Kenneth, M.D, Rosenberg, Anne, M.D, Reintgen, Douglas, M.D, Beitsch, Peter, M.D, Chagpar, Anees, M.D, Julian, Thomas, M.D, Saha, Sukamal, M.D, Mamounas, Eleftherios, M.D, Giuliano, Armando, M.D, Simmons, Rache, M.D
Format: Article
Language:English
Subjects:
Agreements
Axillary
Biological and medical sciences
Breast cancer
Calibration
Diagnostic
Dissection
Gene
General aspects
Gynecology. Andrology. Obstetrics
Histology
Lymphatic system
Mammary gland diseases
Medical sciences
Molecular
Pathology
Patients
Surgery
Test methods
Tumors
Validation studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background When sentinel node dissection reveals breast cancer metastasis, completion axillary lymph node dissection is ideally performed during the same operation. Intraoperative histologic techniques have low and variable sensitivity. A new intraoperative molecular assay (GeneSearch BLN Assay; Veridex, LLC, Warren, NJ) was evaluated to determine its efficiency in identifying significant sentinel lymph node metastases (>.2 mm). Methods Positive or negative BLN Assay results generated from fresh 2-mm node slabs were compared with results from conventional histologic evaluation of adjacent fixed tissue slabs. Results In a prospective study of 416 patients at 11 clinical sites, the assay detected 98% of metastases >2 mm and 88% of metastasis greater >.2 mm, results superior to frozen section. Micrometastases were less frequently detected (57%) and assay positive results in nodes found negative by histology were rare (4%). Conclusions The BLN Assay is properly calibrated for use as a stand alone intraoperative molecular test.
ISSN:0002-9610
1879-1883
DOI:10.1016/j.amjsurg.2007.07.008